• Marco Antonio Zelada Rodríguez, Georgina Cerdà Mas, Laura García Ortiz de Uriarte, F Xavier Martí Company, Natalia Ronquillo Moreno, and Daniel Rodríguez González.
• Unidad de Demencias, Servicio de Geriatría, Hospital Sant Llàtzer, Consorci Sanitari de Terrassa, Terrassa, España. Electronic address: MAZelada@cst.cat.
• Med Clin (Barc). 2020 Apr 24; 154 (8): 301-304.

ObjectiveTo determine the control of systolic blood pressure (SBP) retrospectively according to the recommendations of the ESC/ESH-2018 guideline and its relationship with mortality in octogenarian patients with dementia.Patients And MethodsPreliminary, longitudinal, observational, retrospective study, including 65 patients ≥80 years with diagnosis of dementia and arterial hypertension admitted to a psychogeriatric unit during 2015. The main variables were SBP control according to the recommendations of the ESC/ESH-2018 guideline, considering desirable SBP (130-139mmHg), undesirable SBP (suboptimal <130mmHg and elevated SBP ≥140mmHg) and mortality at 3 years in patients with antihypertensive treatment at discharge (n = 53).ResultsMean age, 86.7±4.31 years (63% women); severe functional dependence (Barthel index <40): 67.7%; severe cognitive impairment (GDS-Riesberg ≥6): 86.3%; high comorbidity: 49%; mortality at 3 years: 41 (63.1%). Patients with arterial hypertension and cardiovascular comorbidity had a higher prescription of antihypertensive drugs (2.07 vs. 1.18, p=.002). Three years mortality was lower in patients with desirable SBP (44.4%) versus undesirable SBP (72.7%) groups, although it was not statistically significant.ConclusionsThe percentage of patients in treatment with suboptimal SBP was elevated especially in hypertensive patients without cardiovascular comorbidity. We found a trend for higher mortality in undesirable SBP groups compared to desirable SBP.Copyright © 2019 Elsevier España, S.L.U. All rights reserved.

25 keywords...

hide…